BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong R, Ji J, Liu H, He X. The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases. Crit Rev Oncol Hematol 2019;143:20-6. [PMID: 31449983 DOI: 10.1016/j.critrevonc.2019.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huo X, Li J, Zhao F, Ren D, Ahmad R, Yuan X, Du F, Zhao J. The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer 2021;21:78. [PMID: 33468087 DOI: 10.1186/s12885-021-07791-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cavaco M, Gaspar D, Arb Castanho M, Neves V. Antibodies for the Treatment of Brain Metastases, a Dream or a Reality? Pharmaceutics 2020;12:E62. [PMID: 31940974 DOI: 10.3390/pharmaceutics12010062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
3 Li WQ, Guo HF, Li LY, Zhang YF, Cui JW. The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively. Cancer Med 2021;10:4677-96. [PMID: 34165267 DOI: 10.1002/cam4.4052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]